{"id":"clinical-evaluation","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T02:31:10.390Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T11:15:32.092823+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07042945","phase":"PHASE1","title":"MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-09","conditions":"HIV Infection","enrollment":28},{"nctId":"NCT05657873","phase":"PHASE2","title":"A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-12-09","conditions":"Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma","enrollment":68},{"nctId":"NCT07349641","phase":"PHASE2","title":"A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-06","conditions":"Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma","enrollment":55},{"nctId":"NCT07496073","phase":"PHASE1","title":"A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2026-03-20","conditions":"Brain (Nervous System) Cancers","enrollment":30},{"nctId":"NCT07433556","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers","status":"RECRUITING","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2026-03-23","conditions":"Healhty","enrollment":86},{"nctId":"NCT06396754","phase":"","title":"Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC","status":"NOT_YET_RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2026-08-01","conditions":"Triple Negative Breast Cancer","enrollment":50},{"nctId":"NCT07495202","phase":"PHASE1","title":"A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine","status":"NOT_YET_RECRUITING","sponsor":"Shanghai JunTop Biosciences Co., LTD","startDate":"2026-03-30","conditions":"Health Volunteer","enrollment":180},{"nctId":"NCT07498556","phase":"NA","title":"Immediate Restoration of a New Implant With High Primary Stability","status":"NOT_YET_RECRUITING","sponsor":"Universidade do Porto","startDate":"2026-03-01","conditions":"Dental Implants, Immediate Dental Implant Loading","enrollment":50},{"nctId":"NCT03907475","phase":"PHASE2","title":"Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-16","conditions":"Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","enrollment":115},{"nctId":"NCT07074405","phase":"NA","title":"Acceptability of Artificial Intelligence in the Diagnosis of Prostate Cancer","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2024-12-02","conditions":"Prostate Cancer","enrollment":51},{"nctId":"NCT07497672","phase":"NA","title":"Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study","status":"NOT_YET_RECRUITING","sponsor":"Myoptechs, Inc","startDate":"2026-04-15","conditions":"Myopia: Refractive Error","enrollment":20},{"nctId":"NCT07494877","phase":"","title":"Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT07497256","phase":"NA","title":"Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Xiamen University","startDate":"2026-04","conditions":"Breast Cancer, Decision Aid, Shared Decision Making","enrollment":160},{"nctId":"NCT06873529","phase":"","title":"The Experiences of Women With Spinal Cord Injury Regarding Fertility, Contraception and Pregnancy","status":"COMPLETED","sponsor":"Gaziler Physical Medicine and Rehabilitation Education and Research Hospital","startDate":"2025-03-20","conditions":"Spinal Cord Injury","enrollment":70},{"nctId":"NCT01834001","phase":"","title":"Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-11-13","conditions":"Prostatic Neoplasms, Prostate Cancer","enrollment":300},{"nctId":"NCT00128973","phase":"","title":"Evaluation of Patients With Immune Function Abnormalities","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2005-09-19","conditions":"Chronic Granulomatous Disease (CGD), X-Linked Severe Combined Immune Deficiency (XSCID), Leukocyte Adhesion Deficiency 1 (LAD)","enrollment":3500},{"nctId":"NCT06417853","phase":"PHASE1","title":"Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)","status":"COMPLETED","sponsor":"Vaxxas Pty Ltd","startDate":"2024-07-31","conditions":"H7N9 Influenza","enrollment":267},{"nctId":"NCT07357909","phase":"PHASE1","title":"Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults","status":"NOT_YET_RECRUITING","sponsor":"Yayasan Inovasi Molekuler Indonesia (Indonesia Molecular Innovation Foundation)","startDate":"2026-05-01","conditions":"Healthy Volunteer","enrollment":50},{"nctId":"NCT06118515","phase":"PHASE1","title":"A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-02-19","conditions":"Congenital Cytomegalovirus Infection","enrollment":12},{"nctId":"NCT06389136","phase":"PHASE3","title":"A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-06-14","conditions":"Atopic Dermatitis","enrollment":200},{"nctId":"NCT06498635","phase":"PHASE3","title":"Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-04-01","conditions":"Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8","enrollment":306},{"nctId":"NCT04387656","phase":"","title":"NCI COVID-19 in Cancer Patients, NCCAPS Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-06-05","conditions":"COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","enrollment":1877},{"nctId":"NCT06562075","phase":"NA","title":"A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Intense Strong","status":"COMPLETED","sponsor":"Bohus Biotech AB","startDate":"2024-09-06","conditions":"Jawline Contour Deficit","enrollment":114},{"nctId":"NCT06674473","phase":"NA","title":"Evaluation of Long-term Isokinetic Training of Knee Joint","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2024-11-06","conditions":"Knee Injuries and Disorders","enrollment":12},{"nctId":"NCT03559283","phase":"NA","title":"fNIRS in the Evaluation of Cognitive-motor Interference in Post-stroke Patients","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2018-11-26","conditions":"D020521","enrollment":11},{"nctId":"NCT00001595","phase":"","title":"An Investigation of Pituitary Tumors and Related Hypothalmic Disorders","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1997-04-21","conditions":"Panhypopituitarism, Gigantism/Acromegaly, Prolactinoma","enrollment":2000},{"nctId":"NCT07253532","phase":"NA","title":"Vibrotactile Balance Belt Effect on Improving Gait","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-03-20","conditions":"Vestibular Hypofunction, Ataxia - Other, Gait Impairment","enrollment":90},{"nctId":"NCT07200466","phase":"NA","title":"Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2025-10-23","conditions":"Endometrial Cancer","enrollment":735},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT04524871","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-11-01","conditions":"Advanced Liver Cancers","enrollment":518},{"nctId":"NCT07105943","phase":"NA","title":"Manipulating Exercise Intensity and Affective Responses for Cardiac Rehabilitation Program Acute Coronary Syndrome Patients","status":"NOT_YET_RECRUITING","sponsor":"Instituto Politécnico de Leiria","startDate":"2026-03-01","conditions":"Affect and Exertion During and Post-exercise","enrollment":52},{"nctId":"NCT04052555","phase":"PHASE1","title":"Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-09-24","conditions":"Bilateral Breast Carcinoma, HER2-Negative Breast Carcinoma, Localized Breast Carcinoma","enrollment":42},{"nctId":"NCT07484282","phase":"","title":"Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-01","conditions":"Cancer, Patients Living With Stage IV or Recurrent Cancer","enrollment":70},{"nctId":"NCT07170033","phase":"NA","title":"The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Istanbul Health and Technology University","startDate":"2024-05-06","conditions":"Rheumatoid Arthritis","enrollment":49},{"nctId":"NCT06075446","phase":"","title":"Calling All Dads! Evaluation of APAs ACT Program: Engaging Fathers to Prevent Adverse Childhood Experiences","status":"ACTIVE_NOT_RECRUITING","sponsor":"Georgia State University","startDate":"2022-03-28","conditions":"Child Abuse","enrollment":500},{"nctId":"NCT07498374","phase":"NA","title":"Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2026-01-21","conditions":"Eosinophilic Chronic Rhinosinusitis With Nasal Polyps","enrollment":192},{"nctId":"NCT07264543","phase":"PHASE2, PHASE3","title":"Early Methylene Blue in the Microhemodynamics of Septic Patients","status":"RECRUITING","sponsor":"Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva","startDate":"2026-01-09","conditions":"Septic Shock, Hypoperfusion","enrollment":50},{"nctId":"NCT03811015","phase":"PHASE3","title":"Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-16","conditions":"Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":636},{"nctId":"NCT05773274","phase":"PHASE2","title":"Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-01-12","conditions":"Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Digestive System Neuroendocrine Tumor G2, Unresectable Digestive System Neuroendocrine Tumor G1","enrollment":100},{"nctId":"NCT07188818","phase":"NA","title":"Clinical Investigation on Lips Treated With HA-filler","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bohus Biotech AB","startDate":"2024-12-09","conditions":"Aesthetic Correction of the Lips","enrollment":100},{"nctId":"NCT07494045","phase":"PHASE2","title":"Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants","status":"NOT_YET_RECRUITING","sponsor":"OPKO Health, Inc.","startDate":"2026-06","conditions":"CKD Stage 3, CKD Stage 4, Secondary Hyperparathyroidism","enrollment":40},{"nctId":"NCT05372640","phase":"PHASE1","title":"Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-08-10","conditions":"Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma","enrollment":45},{"nctId":"NCT06456346","phase":"PHASE3","title":"Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-16","conditions":"Essential Thrombocythemia","enrollment":300},{"nctId":"NCT03648905","phase":"","title":"Clinical Laboratory Evaluation of Chronic Autonomic Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2018-09-06","conditions":"Parkinson's Disease, Multiple System Atrophy, Autonomic Failure","enrollment":89},{"nctId":"NCT06166849","phase":"NA","title":"Clinical Evaluation of an Experimental Remineralization Product","status":"COMPLETED","sponsor":"Ivoclar Vivadent AG","startDate":"2023-03-28","conditions":"White Spot Lesion","enrollment":43},{"nctId":"NCT06185985","phase":"PHASE4","title":"Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms","status":"COMPLETED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2024-03-25","conditions":"Attention-Deficit/Hyperactivity Disorder","enrollment":161},{"nctId":"NCT06498648","phase":"PHASE1, PHASE2","title":"Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-18","conditions":"Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, Advanced Soft Tissue Sarcoma","enrollment":74},{"nctId":"NCT05718375","phase":"PHASE2","title":"Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria","status":"COMPLETED","sponsor":"Curacle Co., Ltd.","startDate":"2023-02-14","conditions":"Diabetic Nephropathies","enrollment":240},{"nctId":"NCT06964529","phase":"NA","title":"Evaluation of the Effects of I-PRF and C-PRF on Gingival Phenotype","status":"COMPLETED","sponsor":"Inonu University","startDate":"2025-02-11","conditions":"Thin Gingival Biotype, Thin Gingiva","enrollment":30},{"nctId":"NCT04097561","phase":"PHASE1","title":"Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-01-13","conditions":"Idiopathic CD4 Lymphopenia","enrollment":20},{"nctId":"NCT05381766","phase":"NA","title":"Building Access to Food Through Systems and Solidarity","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-06-07","conditions":"Diet Habit","enrollment":3200},{"nctId":"NCT01848418","phase":"","title":"Conception of an ICF Core Set for Systemic Sclerosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-10-27","conditions":"Systemic Sclerosis","enrollment":113},{"nctId":"NCT02925871","phase":"NA","title":"The Missing Link- Development and Feasibility Evaluation of Person-centred Transitions From the Stroke Unit to the Home","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2016-04","conditions":"Stroke","enrollment":49},{"nctId":"NCT00005909","phase":"","title":"Study of Alkaptonuria","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2000-06-21","conditions":"Alkaptonuria","enrollment":300},{"nctId":"NCT06602414","phase":"","title":"Evaluation of Clinical Results of Patients Treated Conservatively for Distal Biceps Tendon Lesions","status":"COMPLETED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2024-10-31","conditions":"Tendon Rupture","enrollment":30},{"nctId":"NCT06869447","phase":"NA","title":"New York Better Breathing Study","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-04-15","conditions":"Localized Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":100},{"nctId":"NCT07116109","phase":"NA","title":"Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-07-01","conditions":"Chronic Pain, Post Traumatic Stress Disorder (PTSD)","enrollment":146},{"nctId":"NCT07498309","phase":"PHASE3","title":"Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-09","conditions":"Vaso-Occlusive Crises, Sickle Cell Disease","enrollment":144},{"nctId":"NCT06579469","phase":"","title":"Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2026-01-20","conditions":"B-ALL, Hematologic Malignancy, Solid Tumor","enrollment":100},{"nctId":"NCT06974045","phase":"","title":"Impact of COVID-19 Pandemic on Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2016-04-01","conditions":"Gallstone","enrollment":237},{"nctId":"NCT07495657","phase":"","title":"Pre-Post Multimodal Assessment Of Severe Psoriasis Vulgaris Using Clinical, Dermoscopic And QoL Measures","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-01","conditions":"Psoriasis Vulgaris","enrollment":45},{"nctId":"NCT00001254","phase":"","title":"Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1991-10-29","conditions":"Zollinger Ellison Syndrome","enrollment":273},{"nctId":"NCT07262983","phase":"PHASE1","title":"Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Hyper IgE Syndrome From STAT3 Mutation, Job s Syndrome, HIES","enrollment":20},{"nctId":"NCT05954962","phase":"PHASE4","title":"Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2023-12-23","conditions":"IVF","enrollment":150},{"nctId":"NCT06635356","phase":"","title":"Knee Replacement and Sarcopenia","status":"COMPLETED","sponsor":"Istanbul Physical Medicine Rehabilitation Training and Research Hospital","startDate":"2024-10-01","conditions":"Sarcopenia, Knee Prosthesis, Knee Arthroplasty, Total","enrollment":37},{"nctId":"NCT00029445","phase":"","title":"Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-08-09","conditions":"HIV","enrollment":400},{"nctId":"NCT06875089","phase":"","title":"A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2025-05-05","conditions":"Newborn Screening Programmes for Rare Diseases","enrollment":5000},{"nctId":"NCT03375320","phase":"PHASE3","title":"Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-10-26","conditions":"Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm, Locally Advanced Digestive System Neuroendocrine Neoplasm","enrollment":298},{"nctId":"NCT03784755","phase":"NA","title":"Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2019-11-15","conditions":"Prostate Cancer Metastatic","enrollment":409},{"nctId":"NCT07113691","phase":"PHASE1","title":"Iadademstat + SBRT With Atezo in ES-SCLC","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-01-20","conditions":"Extensive Stage Small Cell Lung Cancer (ES-SCLC)","enrollment":15},{"nctId":"NCT00001204","phase":"","title":"Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1992-01-07","conditions":"Homozygous Familial Hypercholesterolemic","enrollment":73},{"nctId":"NCT07494721","phase":"NA","title":"Effects of Training With a Pressure Cuff on Cellular Energy Activity","status":"NOT_YET_RECRUITING","sponsor":"Spital Thurgau AG","startDate":"2026-07","conditions":"Physical Deconditioning","enrollment":51},{"nctId":"NCT04199104","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-05","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":511},{"nctId":"NCT04986566","phase":"NA","title":"Perioperative Telemonitoring to Optimize Cancer Care and Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2021-10-19","conditions":"Malignant Digestive System Neoplasm","enrollment":134},{"nctId":"NCT04967807","phase":"NA","title":"Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2021-08-05","conditions":"Myocardial Injury, Myocarditis, COVID-19 Vaccination","enrollment":57},{"nctId":"NCT07497295","phase":"","title":"Ultrasound Assessment of Femoral Vein and Inferior Vena Cava Collapsibility to Predict Spinal Anesthesia-Induced Hypotension","status":"RECRUITING","sponsor":"Antalya Training and Research Hospital","startDate":"2026-01-01","conditions":"Post Spinal Anaesthesia Hypotension, Transurethral Resection of the Prostate (TURP)","enrollment":110},{"nctId":"NCT07494071","phase":"NA","title":"Improving Family Communication in Older Adults: A Pilot Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-04","conditions":"Intergenerational Relations","enrollment":40},{"nctId":"NCT05811884","phase":"NA","title":"Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord Injury","status":"SUSPENDED","sponsor":"Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro","startDate":"2030-01","conditions":"Spinal Cord Injuries","enrollment":18},{"nctId":"NCT07011810","phase":"PHASE2","title":"Axatilimab for Sclerotic Chronic Graft-versus-Host Disease","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-08-06","conditions":"Chronic Graft Versus Host Disease","enrollment":50},{"nctId":"NCT05058651","phase":"PHASE2, PHASE3","title":"Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-06-28","conditions":"Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma, Recurrent Extrapulmonary Neuroendocrine Carcinoma","enrollment":189},{"nctId":"NCT05085353","phase":"","title":"Fetal Outcomes Among Pregnant Emergency General Surgery Patients","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2020-02-25","conditions":"Pregnancy Complications, Acute Appendicitis, Acute Cholecystitis","enrollment":3},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT04886960","phase":"PHASE1, PHASE2","title":"pAF for the Treatment of Osteoarthritis","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-07-08","conditions":"Osteo Arthritis Knee","enrollment":60},{"nctId":"NCT07305961","phase":"","title":"National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies","status":"COMPLETED","sponsor":"Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse","startDate":"2025-01-07","conditions":"Scabies","enrollment":1332},{"nctId":"NCT07285018","phase":"PHASE2","title":"A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2026-02-16","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":150},{"nctId":"NCT07496840","phase":"","title":"Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2026-01-15","conditions":"Esophageal Motility Disorders, Achalasia","enrollment":40},{"nctId":"NCT06295809","phase":"PHASE2, PHASE3","title":"A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-04-18","conditions":"Carcinoma, Squamous Cell, Skin Neoplasms","enrollment":46},{"nctId":"NCT06995898","phase":"NA","title":"The Vanguard Study: Testing a New Way to Screen for Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-16","conditions":"Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma","enrollment":24000},{"nctId":"NCT07369856","phase":"NA","title":"Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Cardiology Research UBC","startDate":"2025-11-04","conditions":"Heart Failure, Diuretics","enrollment":300},{"nctId":"NCT00001721","phase":"","title":"Study of Smith-Lemli-Opitz Syndrome","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1998-09-13","conditions":"Smith-Lemli-Opitz Syndrome","enrollment":130},{"nctId":"NCT06545214","phase":"NA","title":"Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-11-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT07174648","phase":"","title":"Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2026-05-01","conditions":"Plague, Bubonic; Plague, Skin, Plague, Pneumonic","enrollment":300},{"nctId":"NCT07371650","phase":"PHASE2","title":"This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza","status":"ACTIVE_NOT_RECRUITING","sponsor":"Traws Pharma, Inc.","startDate":"2025-12-15","conditions":"Influenza","enrollment":105},{"nctId":"NCT00001971","phase":"","title":"Evaluation of Patients With Liver Disease","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1992-05-27","conditions":"Hepatitis D, Hepatitis C, Hepatitis B","enrollment":8050},{"nctId":"NCT06110156","phase":"NA","title":"Population Health Approach to Optimizing Medications in Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2025-05-19","conditions":"Medication Adverse Effects, Older Adults (65 Years and Older), Polypharmacy","enrollment":100},{"nctId":"NCT06527872","phase":"","title":"Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-10-04","conditions":"Lupus Nephritis","enrollment":300},{"nctId":"NCT03233711","phase":"PHASE3","title":"Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-07-05","conditions":"Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma","enrollment":344},{"nctId":"NCT05509777","phase":"PHASE3","title":"A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-03-13","conditions":"Crohn's Disease","enrollment":90},{"nctId":"NCT04139616","phase":"","title":"Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR","status":"RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2020-02-25","conditions":"Conduction Disturbances, Transcatheter Aortic Valve Replacement, Permanent Pacemaker Implantation","enrollment":2000},{"nctId":"NCT07284121","phase":"","title":"A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-07-17","conditions":"Lung Cancer, Hepatocellular Carcinoma","enrollment":700}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":59101,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Patients that under the criteria of the responsible physician receive oral or injectable treatment that are listed in the local Standard of Care"],"phase":"phase_2","status":"active","brandName":"Clinical evaluation","genericName":"Clinical evaluation","companyName":"Hospital Clínico Universitario de Valladolid","companyId":"hospital-cl-nico-universitario-de-valladolid","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":11,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T11:15:32.092823+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}